202 related articles for article (PubMed ID: 29356020)
1. Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B.
Huang H; Wang Q; Du T; Lin C; Lai Y; Zhu D; Wu W; Ma X; Bai S; Li Z; Liu L; Li Q
Prostate; 2018 Apr; 78(5):327-335. PubMed ID: 29356020
[TBL] [Abstract][Full Text] [Related]
2. Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway.
Li Q; Lai Y; Wang C; Xu G; He Z; Shang X; Sun Y; Zhang F; Liu L; Huang H
Oncol Rep; 2016 Jan; 35(1):375-81. PubMed ID: 26497618
[TBL] [Abstract][Full Text] [Related]
3. Matrine inhibits proliferation and induces apoptosis of the androgen‑independent prostate cancer cell line PC-3.
Zhang P; Wang Z; Chong T; Ji Z
Mol Med Rep; 2012 Mar; 5(3):783-7. PubMed ID: 22159447
[TBL] [Abstract][Full Text] [Related]
4. Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway.
Huang H; Du T; Xu G; Lai Y; Fan X; Chen X; Li W; Yue F; Li Q; Liu L; Li K
Int J Oncol; 2017 Feb; 50(2):640-648. PubMed ID: 28000853
[TBL] [Abstract][Full Text] [Related]
5. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells.
Li Q; Huang H; He Z; Sun Y; Tang Y; Shang X; Wang C
Sci China Life Sci; 2018 May; 61(5):550-558. PubMed ID: 29119376
[TBL] [Abstract][Full Text] [Related]
6. Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy.
Luo D; Dai X; Tian H; Fan C; Xie H; Chen N; Wang J; Huang L; Wang H; Wang G; Zhang Y
Phytomedicine; 2023 Jul; 116():154909. PubMed ID: 37269775
[TBL] [Abstract][Full Text] [Related]
7. Matrine inhibits prostate cancer via activation of the unfolded protein response/endoplasmic reticulum stress signaling and reversal of epithelial to mesenchymal transition.
Chang J; Hu S; Wang W; Li Y; Zhi W; Lu S; Shi Q; Wang Y; Yang Y
Mol Med Rep; 2018 Jul; 18(1):945-957. PubMed ID: 29845238
[TBL] [Abstract][Full Text] [Related]
8. Matrine injection inhibits pancreatic cancer growth via modulating carbonic anhydrases- a network pharmacology-based study with in vitro validation.
Xu PL; Cheng CS; Jiao JY; Chen H; Chen Z; Li P
J Ethnopharmacol; 2022 Apr; 287():114691. PubMed ID: 34597654
[TBL] [Abstract][Full Text] [Related]
9. Matrine exerts inhibitory effects in melanoma through the regulation of miR-19b-3p/PTEN.
Wei YP; Wang XH; Liu G; Zhang JF; Yang YX; Zhang J; Song XL; Li ZD; Zhao LD
Int J Oncol; 2018 Aug; 53(2):791-800. PubMed ID: 29845233
[TBL] [Abstract][Full Text] [Related]
10. Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway.
Gu J; Zhang Y; Wang X; Xiang J; Deng S; Wu D; Chen J; Yu L; Zhou Y; Wang Y; Shen J
BMC Complement Med Ther; 2020 Jul; 20(1):214. PubMed ID: 32641029
[TBL] [Abstract][Full Text] [Related]
11. Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro.
Liu XY; Fang H; Yang ZG; Wang XY; Ruan LM; Fang DR; Ding YG; Wang YN; Zhang Y; Jiang XL; Chen HC
Int J Dermatol; 2008 May; 47(5):448-56. PubMed ID: 18412860
[TBL] [Abstract][Full Text] [Related]
12. Identification of Matrine as a Novel Regulator of the CXCR4 Signaling Axis in Tumor Cells.
Jung YY; Um JY; Narula AS; Namjoshi OA; Blough BE; Kumar AP; Ahn KS
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630806
[TBL] [Abstract][Full Text] [Related]
13. Matrine inhibiting pancreatic cells epithelial-mesenchymal transition and invasion through ROS/NF-κB/MMPs pathway.
Huang M; Xin W
Life Sci; 2018 Jan; 192():55-61. PubMed ID: 29155301
[TBL] [Abstract][Full Text] [Related]
14. The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.
Bai S; Chen T; Yu X; Luo M; Chen X; Lin C; Lai Y; Huang H
Oncol Rep; 2017 May; 37(5):2819-2828. PubMed ID: 28440481
[TBL] [Abstract][Full Text] [Related]
15. Matrine reduces the proliferation and invasion of colorectal cancer cells via reducing the activity of p38 signaling pathway.
Ren H; Zhang S; Ma H; Wang Y; Liu D; Wang X; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1049-55. PubMed ID: 25348737
[TBL] [Abstract][Full Text] [Related]
16. Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK.
Liang X; Ju J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786627
[TBL] [Abstract][Full Text] [Related]
17. Matrine involves in the progression of gastric cancer through inhibiting miR-93-5p and upregulating the expression of target gene AHNAK.
Liu ZM; Yang XL; Jiang F; Pan YC; Zhang L
J Cell Biochem; 2020 Mar; 121(3):2467-2477. PubMed ID: 31736157
[TBL] [Abstract][Full Text] [Related]
18. Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo.
Liu T; Song Y; Chen H; Pan S; Sun X
Biol Pharm Bull; 2010; 33(10):1740-5. PubMed ID: 20930385
[TBL] [Abstract][Full Text] [Related]
19. Matrine has pro-apoptotic effects on liver cancer by triggering mitochondrial fission and activating Mst1-JNK signalling pathways.
Cao J; Wei R; Yao S
J Physiol Sci; 2019 Mar; 69(2):185-198. PubMed ID: 30155612
[TBL] [Abstract][Full Text] [Related]
20. Identification of Annexin A2 as a target protein for plant alkaloid matrine.
Wang D; Cao Y; Zheng L; Lv D; Chen L; Xing X; Zhu Z; Li X; Chai Y
Chem Commun (Camb); 2017 May; 53(36):5020-5023. PubMed ID: 28428997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
